The Role of Aryl Hydrocarbon Receptor and Crosstalk with Estrogen Receptor in Response of Breast Cancer Cells to the Novel Antitumor Agents Benzothiazoles and Aminoflavone | ||
| dc.conicet.organizacion | Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncologia "Angel H. Roffo" | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay | |
| dc.conicet.organizacion | Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncologia "Angel H. Roffo" | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay | |
| dc.contributor.author | Callero, Mariana Alejandra | |
| dc.contributor.author | Loaiza Perez, Andrea Irene | |
| dc.date.issued | 2011-06 | |
| dc.description.abstract | Many estrogen-receptor- (ER-) expressing breast cancers become refractory to ER-based therapies. New antitumor drugs like aminoflavone (AF) and benzothiazoles (Bzs) have been developed and have exquisite antitumor activity in ER+MCF-7 and T47D cells and in a MCF-7 nude mouse model. ER(−) breast cancer cells like MDA-MB-231 are less susceptible. We previously found in MCF-7 cells that these drugs activate the aryl hydrocarbon receptor (AhR) via translocation to the nucleus, induction of AhR-specific DNA binding activity, and expression of CYP1A1, whose transcription is controlled by the AhR-ARNT transcription factor. CYP1A1 metabolizes AF and Bz to a species which directly or after further metabolism damages DNA. In contrast an AhR-deficient variant of MCF-7 or cells with predominantly nuclear AhR expression, such as MDA-MB 231, are resistant. Thus, these drugs, unlike other neoplastic agents, require AhR-mediated signaling to cause DNA damage. This is a new treatment strategy for breast cancers with intact AhR signaling. | es |
| dc.description.fil | Fil: Callero, Mariana Alejandra. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncologia "Angel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina | |
| dc.description.fil | Fil: Loaiza Perez, Andrea Irene. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncologia "Angel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Callero, Mariana Alejandra; Loaiza Perez, Andrea Irene; The Role of Aryl Hydrocarbon Receptor and Crosstalk with Estrogen Receptor in Response of Breast Cancer Cells to the Novel Antitumor Agents Benzothiazoles and Aminoflavone; Hindawi Publishing Corporation; International Journal of Breast Cancer; 2011; 6-2011; 1-9 | es |
| dc.identifier.issn | 2090-3189 | |
| dc.identifier.uri | http://hdl.handle.net/11336/12891 | |
| dc.journal.ciudad | El Cairo | es |
| dc.journal.pagination | 1-9 | es |
| dc.journal.pais | Egipto | es |
| dc.journal.title | International Journal of Breast Cancer | es |
| dc.journal.volume | 2011 | es |
| dc.language.iso | eng | es |
| dc.publisher | Hindawi Publishing Corporation | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.hindawi.com/journals/ijbc/2011/923250/ | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262585/ | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by/2.5/ar/ | es |
| dc.subject | Aryl Hydrocarbon Receptor | es |
| dc.subject | Breast Cancer | es |
| dc.subject | Benzothiazole | es |
| dc.subject | Aminoflavone | es |
| dc.subject.classification | Bioquímica y Biología Molecular | es |
| dc.subject.classification | Medicina Básica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | The Role of Aryl Hydrocarbon Receptor and Crosstalk with Estrogen Receptor in Response of Breast Cancer Cells to the Novel Antitumor Agents Benzothiazoles and Aminoflavone | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.16143.pdf
- Tamaño:
- 1.12 MB
- Formato:
- Adobe Portable Document Format